Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Paula Soares, Ana Preto & Manuel Sobrinho-Simões. (2009) BRAFV600E mutation in papillary thyroid carcinoma: a potential target for therapy?. Expert Review of Endocrinology & Metabolism 4:5, pages 467-480.
Read now
Read now
Articles from other publishers (29)
Xin Yao, Wei Jiang, Danhong Yu & Zhaowei Yan. (2019)
Luteolin inhibits proliferation and induces apoptosis of human melanoma cells
in vivo
and
in vitro
by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway
. Food & Function 10:2, pages 703-712.
Crossref
Crossref
Fenghua Li, Yansa Wang & Ying Yan. (2017) Gambogenic acid induces cell growth inhibition, cell cycle arrest and metastasis inhibition in choroidal melanoma in a dose-dependent manner. Experimental and Therapeutic Medicine 13:5, pages 2456-2462.
Crossref
Crossref
Sreeja Sarojini, Andrew Pecora, Natasha Milinovikj, Joseph Barbiere, Saakshi Gupta, Zeenathual M. Hussain, Mehmet Tuna, Jennifer Jiang, Laura Adrianzen, Jaewook Jun, Laurice Catello, Diana Sanchez, Neha Agarwal, Stephanie Jeong, Youngjin Jin, Yvonne Remache, Andre Goy, Alois Ndlovu, Anthony Ingenito & K. Stephen Suh. (2015) A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Research 25:5, pages 376-389.
Crossref
Crossref
Barbara Richichi, Giuseppina Comito, Linda Cerofolini, Gabriele Gabrielli, Alberto Marra, Lisa Moni, Alice Pace, Lucia Pasquato, Paola Chiarugi, Alessandro Dondoni, Lucio Toma & Cristina Nativi. (2013) Multivalent presentation of a hydrolytically stable GM3 lactone mimetic as modulator of melanoma cells motility and adhesion. Bioorganic & Medicinal Chemistry 21:10, pages 2756-2763.
Crossref
Crossref
Jianzhong Qin, Hong Xin & Brian J Nickoloff. (2012) Specifically targeting ERK1 or ERK2 kills Melanoma cells. Journal of Translational Medicine 10:1.
Crossref
Crossref
Konstantinos LinosAndrzej Slominski, Jeffrey S RossJ Andrew Carlson. (2011) Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. Biomarkers in Medicine 5:3, pages 333-360.
Crossref
Crossref
Muriel Vayssade, Nipaporn Sengkhamparn, René Verhoef, Claire Delaigue, Oumou Goundiam, Pascale Vigneron, Alphons G.J. Voragen, Henk A. Schols & Marie‐Danielle Nagel. (2010) Antiproliferative and proapoptotic actions of okra pectin on B16F10 melanoma cells. Phytotherapy Research 24:7, pages 982-989.
Crossref
Crossref
Susan M. Swetter, Mohammed Kashani-Sabet, Peter Johannet, Sunil A. Reddy & Theodore Locke Phillips. 2010. Leibel and Phillips Textbook of Radiation Oncology. Leibel and Phillips Textbook of Radiation Oncology
1459
1472
.
Jeong-Hun Kang, Riki Toita, Tetsuro Tomiyama, Jun Oishi, Daisuke Asai, Takeshi Mori, Takuro Niidome & Yoshiki Katayama. (2009) Cellular signal-specific peptide substrate is essential for the gene delivery system responding to cellular signals. Bioorganic & Medicinal Chemistry Letters 19:21, pages 6082-6086.
Crossref
Crossref
Véronique Mathieu, Christine Pirker, Elisabeth Martin de Lassalle, Mathieu Vernier, Tatjana Mijatovic, Nancy DeNeve, Jean-François Gaussin, Mischael Dehoux, Florence Lefranc, Walter Berger & Robert Kiss. (2009) The sodium pump α1 sub-unit: a disease progression-related target for metastatic melanoma treatment. Journal of Cellular and Molecular Medicine 13:9b, pages 3960-3972.
Crossref
Crossref
D Zamarin, A Vigil, K Kelly, A García-Sastre & Y Fong. (2009) Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Therapy 16:6, pages 796-804.
Crossref
Crossref
J Pinto Couto, H Prazeres, P Castro, J Lima, V Máximo, P Soares & M Sobrinho-Simões. (2009) How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer: Table 1. Journal of Clinical Pathology 62:5, pages 414-421.
Crossref
Crossref
J. Andrew Carlson, Jeffrey S. Ross & Andrze J. Slominski. (2009) New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clinics in Dermatology 27:1, pages 75-102.
Crossref
Crossref
David Stoeter, Nicola de Liguori Carino, Ernest Marshall, Graeme J Poston & Andrew Wu. (2008) Extensive necrosis of visceral melanoma metastases after immunotherapy. World Journal of Surgical Oncology 6:1.
Crossref
Crossref
Vladislava O. Melnikova & Menashe Bar-Eli. (2008) Searching for the Achilles’ heel of melanoma cells: new treatment modalities. Pigment Cell & Melanoma Research 21:5, pages 505-506.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Oncology 20:2, pages 234-244.
Crossref
Crossref
SubbaRao V. Madhunapantula & Gavin P. Robertson. (2008) Is B-Raf a Good Therapeutic Target for Melanoma and Other Malignancies?. Cancer Research 68:1, pages 5-8.
Crossref
Crossref
Jürgen Eberle, Lothar F. Fecker, Amir M. Hossini, Bahtier M. Kurbanov & Henry Fechner. (2007) Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma. Experimental Dermatology 17:1, pages 1-11.
Crossref
Crossref
R. Molife & B.W. Hancock. (2002) Adjuvant therapy of malignant melanoma. Critical Reviews in Oncology/Hematology 44:1, pages 81-102.
Crossref
Crossref
C. Garbe. 1998. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
799
829
.
Marie-France Demierre & Howard K. Koh. (1997) Adjuvant therapy for cutaneous malignant melanoma. Journal of the American Academy of Dermatology 36:5, pages 747-764.
Crossref
Crossref
P. M. Schlag & M. Hünerbein. 1997. Forschung in der Chirurgie. Forschung in der Chirurgie
170
187
.
Andreas Barth & Donald L. Morton. (1995) The role of adjuvant therapy in melanoma management. Cancer 75:S2, pages 726-734.
Crossref
Crossref
C. Garbe. 1995. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
674
702
.
Constantin E. Orfanos & Claus GarbeConstantin E. Orfanos & Claus Garbe. 1995. Therapie der Hautkrankheiten. Therapie der Hautkrankheiten
855
889
.
A.S. Coates & E. Segelov. (1994) Long term response to chemotherapy in patients with visceral metastatic melanoma. Annals of Oncology 5:3, pages 249-251.
Crossref
Crossref
C. Garbe & C. E. Orfanos. 1993. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
229
250
.
Alan S. Coates. (1992) Systemic chemotherapy for malignant melanoma. World Journal of Surgery 16:2, pages 277-281.
Crossref
Crossref
Annamaria Calabro, S. Eva Singletary, Cesar H. Carrasco & Sewa S. Legha. (1990) Intraarterial infusion chemotherapy in regionally advanced malignant melanoma. Journal of Surgical Oncology 43:4, pages 239-244.
Crossref
Crossref